Affect E2 binding or binding to estrogenresponsive DNA sequences (16, 17). In vitro
Affect E2 binding or binding to estrogenresponsive DNA sequences (16, 17). In vitro studies have demonstrated that mutations of these residues have the capacity to convert antiestrogens into agonists (18,…